{"id":"W2600127085","doi":"10.1111/dom.12958","title":"Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Sitagliptin; Medicine; Internal medicine; Endocrinology; Placebo; Metformin; Glycated hemoglobin; Type 2 diabetes; Glucagon receptor; Blood pressure; Lipid profile; Glucagon-like peptide 1 receptor; Glucagon; Diabetes mellitus; Insulin; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001278757,0.0005045653,0.000885938,0.0002207811,0.0003861523,0.0002139316,0.0001842476,0.0001234824,0.00003765795],"category_scores_gemma":[0.00009984486,0.0003317222,0.00008875435,0.0001666925,0.0002863644,0.0004694327,0.0001398643,0.0001399773,0.00005319862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009506092,"about_ca_system_score_gemma":0.00005399038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002763,"about_ca_topic_score_gemma":0.0001031679,"domain_scores_codex":[0.9979747,0.00006896356,0.0002458905,0.0006244835,0.0003622421,0.0007237143],"domain_scores_gemma":[0.9984287,0.0001028489,0.0002256433,0.0007601263,0.0001530239,0.0003296662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001195734,0.00217694,0.9805034,0.0001373335,0.0006474002,0.00002295453,0.0002391703,5.4268e-7,0.0002251014,0.0001429048,0.0003100025,0.01547469],"study_design_scores_gemma":[0.009203386,0.002088303,0.9490238,0.0002351373,0.001088524,3.180846e-7,0.00005981646,0.00002579867,0.006585,0.00002738112,0.03146064,0.0002018707],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934139,0.003065865,7.725684e-7,0.00009204006,0.0001621533,0.001190114,0.00006516578,0.00008054614,0.001929499],"genre_scores_gemma":[0.9952893,0.001382416,0.0006829353,0.0002621287,0.0001587394,0.0001218392,0.0003064781,0.00005289957,0.001743239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03147956,"threshold_uncertainty_score":0.9999135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008540022634781116,"score_gpt":0.2100609367524394,"score_spread":0.2015209141176582,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}